Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

PHASE2CompletedINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

March 31, 2007

Conditions
DementiaAlzheimer's Disease
Interventions
DRUG

Rasagiline

Trial Locations (58)

2076

Hornsby Kur-ing-gai Hospital, Rehabilitation and Aged Care Service, Hornsby

2193

Milpark Hospital, Parktown

2196

Suite C, Black C, Sandton

2197

The Memory Centre, Johannesburg

3081

Heidelberg Repatriation Hospital, Heidelberg West

3101

St. George's Hospital, Kew

3192

Aged Mental Health Research Unit - Kingston Centre, Cheltenham

3350

Ballarat Health Service - Queen Elizabeth Center, Ballarat

3610

Crompton Medical Centre West, Pinetown

3900

Richard's Bay Trial Centre, Richard's Bay

4001

St. Augustine's Medical Mews., Durban

5011

The Queen Elizabeth Hospital, Woodville

6009

McCusker Foundation for Alzheimer's Disease Research, Nedlands

7500

Panorama Medical Centre, Panorama

7530

Dr. Felix Potocnik, Oakdale

7800

Constantiaberg Medi Clinic, Plumstead

9301

Bloemfontein Medi Clinic, Westdene

Westdene Research Centre, Westdene

30033

Dekalb Neurology Associates, LLC, Decatur

30329

Emory University Wesley Woods Health Center, Altanta

33407

Premiere Research Institute, West Palm Beach

33409

North Broward Medical Center/Memory Disorder Center, West Palm Beach

35801

Collaborative Neuroscience Network, Huntsville

North Alabama Neuroscience Research, Huntsville

42003

Four Rivers Clinical Research, Paducah

43210

Ohio State University, Department of Neurology, Columbus

46805

Fort Wayne Neurological Center, Fort Wayne

49684

Northern Michigan Neurology, Traverse City

58104

Odyssey Research, Fargo

60610

Radiant Research, Chicago

66214

Mid America Neuroscience Institute, Lenexa

70112

Tulane University Health Sciences Center, Dept of Psychiatry and Neurology, New Orleans

72205

Clinical Study Centers, LLC, Little Rock

73118

Pahl Brain Associates, Oklahoma City

77030

Premiere Research Institute, Houston

University of Texas Mental Sciences Institute, Houston

80262

University of Colorado Health Sciences Center, Denver

90404

Neurological Research Institute, Santa Monica

92845

Collaborative Neuroscience Network, Garden Grove

93720

Margolin Brain Institute, Fresno

94109

San Francisco Clinical Research Center, San Francisco

94705

East Bay Region Associates in Neurology, Berkeley

98335

Peninsula Internal Medicine Associates, Gig Harbor

98405

Internal Medicine Northwest, Tacoma

85741-3537

Northwest Neurospecialists, PLLC, Tucson

02115

Department of Neurology - Brigham and Women's Hospital, Boston

08854

University Behavioral Healthcare Centre Department of Psychiatry, Piscataway

29406-6076

Medical University of South Carolina Alzheimer's Research and Clinical Programs, North Charleston

77030-2744

Department of Neurology Baylor College of Medicine, Houston

QLD4032

Prince Charles Hospital - Dept. of Geriatrics, Chermside

NSW 2250

Central Coast Neuroscience Research, East Gosford

T5G 0B7

Glenrose Rehabilitation Hospital, Edmonton

R3C 0N2

Memory Disorder Clinic/Winnipeg Clinic, Winnipeg

N6A 4V2

Dept. of Clinical Neurological Sciences - University of Western Ontario, London

K9H 2P4

155974 Ont. Inc., Peterborough

M3B 2W7

Neurology Research Inc., Toronto

0041

Willows Medical Center, Pretoria

0181

Little Company of Mary Hospital, Pretoria

All Listed Sponsors
collaborator

Eisai Inc.

INDUSTRY

lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT00104273 - Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD) | Biotech Hunter | Biotech Hunter